Reyon Pharmaceutical Co Ltd Financial Flexibility Index
Reyon Pharmaceutical Co Ltd financial flexibility index. Reyon Pharmaceutical Co Ltd (102460) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of ₩-740.22 Million (operating CF ₩-1.73 Billion minus capex ₩989.13 Million) represents 0% of total liabilities (₩239.99 Billion). Explore 102460 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Reyon Pharmaceutical Co Ltd (2008–2024)
Financial flexibility index of Reyon Pharmaceutical Co Ltd from 2008 to 2024. Historical Financial Flexibility Index trend for Reyon Pharmaceutical Co Ltd across 13 annual periods. Check 102460 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Reyon Pharmaceutical Co Ltd Financial Flexibility Index by Year (2008–2024)
Reyon Pharmaceutical Co Ltd financial flexibility index by year from 2008 to 2024. Year-by-year free cash flow to debt coverage for Reyon Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 102460 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.06x | ₩14.59 Billion | ₩-1.44 Billion | ₩250.05 Billion | ▼ -60.9% |
| 2023 | 0.15x | ₩37.52 Billion | ₩8.65 Billion | ₩251.15 Billion | ▼ -50.7% |
| 2022 | 0.30x | ₩71.86 Billion | ₩8.73 Billion | ₩236.93 Billion | ▼ -45.1% |
| 2021 | 0.55x | ₩128.66 Billion | ₩11.68 Billion | ₩232.74 Billion | ▼ -15.0% |
| 2020 | 0.65x | ₩56.91 Billion | ₩4.60 Billion | ₩87.52 Billion | ▼ -12.4% |
| 2019 | 0.74x | ₩38.75 Billion | ₩-12.18 Billion | ₩52.19 Billion | ▲ +14.1% |
| 2018 | 0.65x | ₩50.62 Billion | ₩11.45 Billion | ₩77.77 Billion | ▲ +121.6% |
| 2017 | 0.29x | ₩20.91 Billion | ₩16.76 Billion | ₩71.18 Billion | ▼ -29.5% |
| 2016 | 0.42x | ₩12.68 Billion | ₩9.47 Billion | ₩30.44 Billion | ▼ -52.9% |
| 2012 | 0.89x | ₩27.07 Billion | ₩24.65 Billion | ₩30.57 Billion | ▲ +43.2% |
| 2011 | 0.62x | ₩17.76 Billion | ₩15.34 Billion | ₩28.73 Billion | ▲ +35.0% |
| 2009 | 0.46x | ₩10.14 Billion | ₩8.68 Billion | ₩22.15 Billion | ▲ +28.8% |
| 2008 | 0.36x | ₩8.04 Billion | ₩5.99 Billion | ₩22.64 Billion | — |